|
|
Article: FDA encourages new applications for drugs to treat internal contamination.
- Article from:
- Health & Medicine Week
- Article date:
- October 6, 2003
CopyrightCOPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2003 OCT 6 - (NewsRx.com & NewsRx.net) -- As part of its continuing efforts to provide the American public access to treatments in the event of a terrorist attack, the U.S. Food and Drug Administration (FDA) announced that it had determined conditions under which two drugs, pentetate calcium trisodium (Ca-DTPA) and pentetate zinc trisodium (Zn-DTPA), are safe and effective for treatment of certain kinds of radiation exposure.
FDA is calling for manufacturers to use these findings to submit marketing applications for Ca-DTPA and Zn-DTPA products for use as medical countermeasures.
Through analysis of the medical reports of patients treated with Ca-DTPA ...